Public Profile

Isotopia Molecular Imaging Ltd

Isotopia Molecular Imaging Ltd., a leading name in the field of molecular imaging, is headquartered in Israel (IL) and operates extensively across Europe and North America. Founded in 2006, the company has established itself as a pioneer in the development of innovative radiopharmaceuticals and imaging agents, catering primarily to the medical and research sectors. Isotopia's core offerings include a range of high-quality radiotracers and diagnostic imaging solutions that enhance the accuracy of disease detection and treatment monitoring. What sets Isotopia apart is its commitment to quality and compliance with stringent regulatory standards, ensuring that its products meet the highest industry benchmarks. With a strong market position, Isotopia has achieved significant milestones, including collaborations with leading healthcare institutions, solidifying its reputation as a trusted partner in molecular imaging.

DitchCarbon Score

How does Isotopia Molecular Imaging Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

Isotopia Molecular Imaging Ltd's score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Isotopia Molecular Imaging Ltd's reported carbon emissions

Isotopia Molecular Imaging Ltd, headquartered in Israel (IL), currently does not have any publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may still be engaged in sustainability initiatives or industry practices aimed at reducing environmental impact, although specific details are not provided. As the industry increasingly focuses on climate action, Isotopia's future commitments and strategies will be crucial in aligning with global sustainability goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Isotopia Molecular Imaging Ltd's primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Isotopia Molecular Imaging Ltd is headquartered in IL, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Isotopia Molecular Imaging Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Novartis

CH
Research and development services (73)
Updated 3 days ago

Blue Earth Diagnostics Limited

GB
Chemicals nec
Updated 8 days ago

CellBion Co., Ltd.

KR
Chemicals nec
Updated 8 days ago

Hengrui Pharma

CN
Chemicals nec
Updated 8 days ago

University Of California, San Francisco

US
Health and social work services (85)
Updated 8 days ago

Telix Pharmaceuticals

US
Chemicals nec
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers